These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1751 related articles for article (PubMed ID: 19336687)

  • 21. The various phenotypes of diabetes and the endoplasmic reticulum of the beta cell.
    Ionescu-Tîrgovişte C; Guja C
    Rom J Intern Med; 2007; 45(3):287-91. PubMed ID: 18333363
    [No Abstract]   [Full Text] [Related]  

  • 22. The mechanisms linking adiposopathy to type 2 diabetes.
    Yang J; Kang J; Guan Y
    Front Med; 2013 Dec; 7(4):433-44. PubMed ID: 24085616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging Concepts in Diabetes: Mitochondrial Dynamics and Glucose Homeostasis.
    Gómez-Valadés AG; Gonzalez-Franquesa A; Gama-Perez P; Claret M; Garcia-Roves PM
    Curr Diabetes Rev; 2017; 13(4):370-385. PubMed ID: 26456359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathophysiology of non-insulin-dependent diabetes mellitus (NIDDM).
    Beck-Nielsen H; Henriksen JE; Vaag A; Hother-Nielsen O
    Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S13-25. PubMed ID: 8529505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Focus issue: diabetes--fighting fat on multiple fronts.
    Adler EM
    Sci STKE; 2005 Jan; 2005(268):eg2. PubMed ID: 15671478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of lipids in insulin resistance and type 2 diabetes mellitus development.
    Mingrone G; Castagneto M
    Nutrition; 1999 Jan; 15(1):64-6. PubMed ID: 9918070
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin deficiency vs insulin resistance in NIDDM: concluding remarks by a 'biased' observer.
    Cerasi E
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S161-4. PubMed ID: 8894502
    [No Abstract]   [Full Text] [Related]  

  • 28. Goals of treatment for type 2 diabetes: beta-cell preservation for glycemic control.
    Marchetti P; Lupi R; Del Guerra S; Bugliani M; D'Aleo V; Occhipinti M; Boggi U; Marselli L; Masini M
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S178-83. PubMed ID: 19875548
    [No Abstract]   [Full Text] [Related]  

  • 29. Adjusting glucose-stimulated insulin secretion for adipose insulin resistance: an index of β-cell function in obese adults.
    Malin SK; Kashyap SR; Hammel J; Miyazaki Y; DeFronzo RA; Kirwan JP
    Diabetes Care; 2014 Nov; 37(11):2940-6. PubMed ID: 25139885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
    Virally M; Blicklé JF; Girard J; Halimi S; Simon D; Guillausseau PJ
    Diabetes Metab; 2007 Sep; 33(4):231-44. PubMed ID: 17703979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced skeletal muscle secreted frizzled-related protein 3 is associated with inflammation and insulin resistance.
    Pachori AS; Madan M; Nunez Lopez YO; Yi F; Meyer C; Seyhan AA
    Obesity (Silver Spring); 2017 Apr; 25(4):697-703. PubMed ID: 28240822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes.
    DeFronzo RA; Tripathy D
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S157-63. PubMed ID: 19875544
    [No Abstract]   [Full Text] [Related]  

  • 33. Loss of β-arrestin2 mediates pancreatic-islet dysfunction in mice.
    Zhang M; Zhu Y; Mu K; Li L; Lu J; Zhao J; Huang X; Wang C; Jia W
    Biochem Biophys Res Commun; 2013 Jun; 435(3):345-9. PubMed ID: 23660189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longitudinal decline of β-cell function: comparison of a direct method vs a fasting surrogate measure: the Insulin Resistance Atherosclerosis Study.
    Festa A; Haffner SM; Wagenknecht LE; Lorenzo C; Hanley AJ
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4152-9. PubMed ID: 23884776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The regulation of amylin and insulin gene expression and secretion.
    Cluck MW; Chan CY; Adrian TE
    Pancreas; 2005 Jan; 30(1):1-14. PubMed ID: 15632693
    [No Abstract]   [Full Text] [Related]  

  • 36. Insulin resistance in non-insulin-dependent diabetes mellitus. A review.
    Alzaid AA
    Acta Diabetol; 1996 Jul; 33(2):87-99. PubMed ID: 8870808
    [No Abstract]   [Full Text] [Related]  

  • 37. Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities.
    LeRoith D
    Am J Med; 2002 Oct; 113 Suppl 6A():3S-11S. PubMed ID: 12431757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue.
    Iozzo P
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S168-73. PubMed ID: 19875546
    [No Abstract]   [Full Text] [Related]  

  • 39. No association between variation in the NR4A1 gene locus and metabolic traits in white subjects at increased risk for type 2 diabetes.
    Müssig K; Machicao F; Machann J; Schick F; Claussen CD; Stefan N; Fritsche A; Häring HU; Staiger H
    BMC Med Genet; 2010 Jun; 11():84. PubMed ID: 20525362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Amylin/IAPP (islet amyloid polypeptide)--physiology and clinical significance].
    Ludvik B
    Wien Klin Wochenschr; 1997 Jun; 109(11):379-83. PubMed ID: 9281227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 88.